X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4258) 4258
Publication (332) 332
Report (82) 82
Book Review (68) 68
Government Document (53) 53
Book Chapter (36) 36
Newspaper Article (20) 20
Book / eBook (13) 13
Dissertation (6) 6
Conference Proceeding (5) 5
Trade Publication Article (3) 3
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2637) 2637
index medicus (1999) 1999
oncology (1757) 1757
female (1713) 1713
platinum (1681) 1681
chemotherapy (1449) 1449
cisplatin (1402) 1402
cancer (1360) 1360
middle aged (1036) 1036
male (1035) 1035
animals (990) 990
aged (947) 947
antineoplastic combined chemotherapy protocols - therapeutic use (886) 886
adult (822) 822
pharmacology & pharmacy (671) 671
ovarian neoplasms - drug therapy (601) 601
ovarian cancer (571) 571
treatment outcome (555) 555
carboplatin (548) 548
antineoplastic agents - therapeutic use (521) 521
antineoplastic agents - administration & dosage (495) 495
care and treatment (494) 494
organoplatinum compounds - administration & dosage (468) 468
antineoplastic agents - pharmacology (459) 459
cisplatin - administration & dosage (439) 439
mice (438) 438
analysis (413) 413
toxicity (412) 412
lung neoplasms - drug therapy (409) 409
research (394) 394
carcinoma (393) 393
cell line, tumor (389) 389
platinum compounds - administration & dosage (379) 379
paclitaxel (375) 375
oxaliplatin (347) 347
antineoplastic agents (343) 343
carcinoma, non-small-cell lung - drug therapy (330) 330
platinum compounds (330) 330
antineoplastic agents - adverse effects (329) 329
cytotoxicity (329) 329
drugs (326) 326
antineoplastic combined chemotherapy protocols - adverse effects (323) 323
tumors (323) 323
neoplasm staging (320) 320
biochemistry & molecular biology (319) 319
disease-free survival (316) 316
rats (314) 314
antineoplastic agents - chemistry (311) 311
aged, 80 and over (307) 307
drug resistance, neoplasm (299) 299
antimitotic agents (293) 293
neoplasms - drug therapy (286) 286
apoptosis (285) 285
medicine & public health (283) 283
survival (283) 283
platinum complexes (282) 282
drug therapy (280) 280
platinum-based chemotherapy (278) 278
ovarian neoplasms - pathology (276) 276
prognosis (276) 276
dose-response relationship, drug (275) 275
organoplatinum compounds - pharmacology (275) 275
health aspects (266) 266
antineoplastic agents - pharmacokinetics (263) 263
hematology, oncology and palliative medicine (259) 259
cancer therapies (258) 258
therapy (255) 255
cisplatin - pharmacology (254) 254
retrospective studies (251) 251
drug administration schedule (244) 244
pharmacokinetics (244) 244
carboplatin - administration & dosage (243) 243
chemistry, inorganic & nuclear (240) 240
in-vitro (240) 240
obstetrics & gynecology (240) 240
platinum compounds - therapeutic use (240) 240
dna (237) 237
survival analysis (221) 221
gemcitabine (220) 220
article (210) 210
antitumor-activity (209) 209
trial (209) 209
organoplatinum compounds - therapeutic use (207) 207
lung cancer (206) 206
paclitaxel - administration & dosage (206) 206
phase-ii (206) 206
resistance (206) 206
organoplatinum compounds - pharmacokinetics (205) 205
deoxycytidine - analogs & derivatives (204) 204
chemistry, multidisciplinary (202) 202
survival rate (201) 201
antineoplastic combined chemotherapy protocols - administration & dosage (198) 198
organoplatinum compounds - adverse effects (197) 197
nanoparticles (195) 195
lung neoplasms - pathology (193) 193
neoplasm recurrence, local - drug therapy (189) 189
cell lung-cancer (188) 188
drug resistance (183) 183
lung cancer, non-small cell (183) 183
cisplatin - therapeutic use (178) 178
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Engineering & Comp. Sci. - Stacks (4) 4
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Innis College - Stacks (1) 1
Robarts - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4404) 4404
Japanese (15) 15
Russian (12) 12
French (11) 11
Chinese (8) 8
German (4) 4
Hungarian (4) 4
Spanish (4) 4
Polish (3) 3
Dutch (2) 2
Italian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Serbian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advanced Drug Delivery Reviews, ISSN 0169-409X, 11/2013, Volume 65, Issue 13-14, pp. 1667 - 1685
Journal Article
Investigational new drugs, ISSN 0167-6997, 2015, Volume 33, Issue 1, pp. 201 - 214
Background This phase I/II study determined the maximal tolerable dose, dose limiting toxicities, antitumor activity, the pharmacokinetics and pharmacodynamics... 
NAMI-A | Ruthenium | Phase I | Medicine & Public Health | Gemcitabine | Non-small cell lung cancer | Oncology | Phase II | Pharmacology/Toxicology | Clinical study | TRANS-IMIDAZOLEDIMETHYLSULFOXIDE-TETRACHLORORUTHENATE | DNA-BINDING | METASTASIS | CHEMICAL-STABILITY | TUMORS | PLATINUM COMPLEXES | INHIBITION | LIQUID-CHROMATOGRAPHY | ONCOLOGY | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | CYTOTOXICITY | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Ruthenium - administration & dosage | Deoxycytidine - pharmacokinetics | Ruthenium - adverse effects | Adult | Deoxycytidine - adverse effects | Dimethyl Sulfoxide - administration & dosage | Female | Ruthenium - blood | Dimethyl Sulfoxide - adverse effects | Organometallic Compounds - adverse effects | Deoxycytidine - administration & dosage | Carcinoma, Non-Small-Cell Lung - metabolism | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Ruthenium - pharmacokinetics | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Dimethyl Sulfoxide - analogs & derivatives | Deoxycytidine - analogs & derivatives | Dimethyl Sulfoxide - pharmacokinetics | Organometallic Compounds - administration & dosage | Complications and side effects | Dosage and administration | Research | Lung cancer, Non-small cell | Drug therapy | Studies | Clinical trials | Lung cancer | Pharmaceutical sciences | Clinical outcomes | Index Medicus
Journal Article
Dalton Transactions, ISSN 1477-9226, 2016, Volume 45, Issue 33, pp. 12992 - 13004
Anticancer platinum (Pt) complexes have long been considered to be one of the biggest success stories in the history of medicinal inorganic chemistry. Yet... 
Journal Article
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast... 
Radiation therapy | Early breast cancer | St Gallen Consensus | Systemic adjuvant therapies | Surgery | early breast cancer | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | radiation therapy | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | systemic adjuvant therapies | surgery | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article
Journal Article
Advanced Materials, ISSN 0935-9648, 08/2014, Volume 26, Issue 31, pp. 5550 - 5557
Journal Article